---
type: medication
drug_class: not-applicable
tags: [malaria/cerebral, pathophysiology/misclassified]
evidence_grade_max: expert_opinion
claim_count: 2
last_regen: 2026-05-13T19:14:02Z
---

# Neuroinflammation

**Therapeutic category:** _Not applicable — entity is a pathophysiological process, not a medication._
**Drug group:** _N/A_
**Drug class:** _N/A_
**Controlled substance:** _N/A_

## Overview

Neuroinflammation is a CNS inflammatory response, not a therapeutic agent. Classifier hint (`medication`) does not match the underlying claim set, which positions neuroinflammation as an *effect* of [[inflammatory-mediators]] [c:327c6bed] and [[cerebral-malaria]] [c:e402ac3d]. Note retained as stub; recommend reclassification to `concept` or `condition`.

## Indication (Why is this medication prescribed?)

_Not applicable — not a prescribable agent._

## Mechanism of Action (How does it work?)

_Not applicable as a drug._ Upstream drivers in current corpus: inflammatory mediators (cytokines, chemokines) drive neuroinflammation in inpatient endemic settings [c:327c6bed] (pending review); cerebral malaria causes neuroinflammation [c:e402ac3d] (pending review). Both `expert_opinion` grade.

```mermaid
flowchart LR
  A[Cerebral malaria] -->|releases| B[Inflammatory mediators]
  B -->|drive| C[Neuroinflammation]
```
Cascade per [c:e402ac3d] and [c:327c6bed].

## Dosage and Administration

_No dose claims in current corpus._

## Contraindications (When not to use it)

_No contraindication claims in current corpus._

## Warnings and Precautions

_No warning claims in current corpus._

## Side Effects

_No adverse-effect claims in current corpus._

## Drug Interactions

_No interaction claims in current corpus._

## Storage and Stability

_Not applicable._

---
*Last regenerated: 2026-05-13T19:14:02Z. Source claims: 2. Evidence mix: 2 expert_opinion (both pending review). Entity-type mismatch flagged — recommend reclassify from `medication` to `concept`/`condition`.*
